Capnography Equipment Market

The global capnography equipment market is valued at USD 0.67 billion in 2026 and projected to reach USD 0.87 billion by 2031, at a CAGR of 5.5% during the forecast period.

The capnography equipment market is expanding mainly due to the increasing prevalence of respiratory ailments like COPD, asthma, and sleep apnea, along with more surgical procedures involving continuous patient monitoring. Growing recognition of the need to detect respiratory compromise early, improvements in sensor technology and portable capnography systems, and the adoption of capnography in emergency and critical care settings also drive demand. Also, the implementation of capnography in procedural sedation, the transition towards non-invasive monitoring, and positive government guidelines favoring patient safety standards in hospitals and ambulatory care facilities are important drivers accelerating market growth.

To know about the assumptions considered for the study download the pdf brochure

Prominent market players include Medtronic (Ireland), Koninklijke Philips N.V. (Netherlands), Masimo (US), GE HealthCare (US), and Becton, Dickinson and Company (US). Major players in the capnography devices industry use several key tactics. One key tactic is continuous investment in R&D to introduce novel, ergonomically improved, and technologically advanced instruments that improve patient outcomes. Additionally, businesses use strategic partnerships, mergers, and acquisitions to expand product lines, strengthen their geographic footprint, and reach new customers. Leading manufacturers also focus on expanding in emerging markets by providing affordable solutions suited to the needs of low- and middle-income countries. Establishing training programs and surgeon education initiatives is another essential tactic to boost capnography device adoption and proficiency.

• In May 2026: Medtronic received FDA 510(k) clearance for the Capnostream 35 Portable Respiratory Monitor (PM35MN), a portable device that provides continuous monitoring of end-tidal carbon dioxide (EtCO₂) and respiratory parameters, supporting respiratory monitoring across various clinical settings.

• In the same month, Medtronic and GE HealthCare expanded their multiyear global strategic alliance to integrate Medtronic’s Microstream capnography technology into GE HealthCare’s patient-monitoring platforms, enabling broader access to integrated respiratory and multiparameter monitoring solutions.

Medtronic (Ireland)

Medtronic plc is a major global healthcare-technology company headquartered in Dublin, Ireland, operating across more than 150 countries with over 90,000 employees, and offering a broad portfolio of devices, therapies, and monitoring solutions. Medtronic’s participation is anchored by its Microstream technology, designed for continuous end-tidal CO₂ monitoring across both intubated and non-intubated patients (neonate to adult), with advanced algorithms to reduce nuisance alarms and provide early detection of respiratory compromise. Medtronic has also strengthened its market position through strategic collaborations, such as integrating its Microstream capnography module with GE HealthCare’s CARESCAPE monitoring platform under FDA and CE clearance, thereby expanding its ecosystem presence and compatibility. Thus, Medtronic is a key player in the capnography devices market, leveraging its global scale, broad device portfolio, algorithm-enabled monitoring capabilities, and strategic integrations to support adoption in perioperative, ICU, and broader hospital settings.

Koninklijke Philips N.V. (Netherlands)

Koninklijke Philips N.V. (Philips) is a Dutch multinational health-technology company and a major player in the global capnography devices market, offering standalone and integrated CO₂ monitoring solutions, including mainstream and sidestream sensors for neonates through adults. Through strategic acquisitions and partnerships, Philips leverages its broad patient-monitoring and connected-care platform to embed capnography capabilities across settings (OR, ICU, emergency, general ward) and geographies. Its strengths in the capnography segment include strong brand recognition, global distribution reach, and versatile monitoring form factors; however, challenges include intense competitive pressure from other established device makers and the need to continually innovate in sensor, algorithm, and connectivity features to differentiate in a moderately growing market.

Market Ranking:

In the global capnography equipment market, Medtronic (Ireland) holds a leading position, supported by its comprehensive Microstream capnography portfolio and Capnostream respiratory monitors used across critical care, procedural sedation, emergency, and medical-surgical settings. Koninklijke Philips N.V. (Netherlands) maintains a strong position with its IntelliVue and Efficia patient-monitoring platforms, complemented by a broad range of CO₂ sampling lines for intubated and non-intubated patients. Masimo (US) is a prominent player, supported by its NomoLine sidestream and multigas monitoring solutions, including EMMA capnographs and ISA gas analyzers, which enable respiratory monitoring across operating rooms, ICUs, emergency care, and transport settings. GE HealthCare (US) has established a significant presence by integrating CO₂ monitoring and waveform capnography capabilities into its CARESCAPE patient-monitoring ecosystem, enabling simultaneous monitoring of respiratory and other vital parameters. Becton, Dickinson and Company (US) participates through its BD Alaris EtCO₂ Module, which provides continuous end-tidal CO₂ monitoring and integrates with infusion-management systems to support early detection of respiratory compromise, particularly during opioid therapy.

Related Reports:

Capnography Equipment Market by Product (Equipment (Multiparameter, Standalone), Software, Accessories & Disposables), Technology (Mainstream, Microstream), Application (Cardiac Care, Respiratory Monitoring), End User, Region - Global Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]